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Objective: Defective mucus production in the pancreas may be an important factor
in the initiation and progression of chronic pancreatitis (CP), therefore we aimed to (i)
investigate the qualitative and quantitative changes of mucus both in human CP and
in an experimental pancreatitis model and (ii) to correlate the mucus phenotype with
epithelial ion transport function.
Design: Utilizing human tissue samples and a murine model of cerulein induced CP we
measured pancreatic ductal mucus content by morphometric analysis and the relative
expression of different mucins in health and disease. Pancreatic fluid secretion in CP
model was measured in vivo by magnetic resonance cholangiopancreatography (MRCP)
and in vitro on cultured pancreatic ducts. Time-changes of ductal secretory function
were correlated to those of the mucin production.
Results: We demonstrate increased mucus content in the small pancreatic ducts in CP.
Secretory mucins MUC6 and MUC5B were upregulated in human, Muc6 in mouse CP.
In vivo and in vitro fluid secretion was decreased in cerulein-induced CP. Analysis of time-
course changes showed that impaired ductal ion transport is paralleled by increased
Muc6 expression.
Conclusion: Mucus accumulation in the small ducts is a combined effect of
mucus hypersecretion and epithelial fluid secretion defect, which may lead to ductal
obstruction. These results suggest that imbalance of mucus homeostasis may have an
important role in the early-phase development of CP, which may have novel diagnostic
and therapeutic implications.
Keywords: chronic pancreatitis, mucus, ductal epithelium, experimental pancreatitis, epithelial fluid secretion
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INTRODUCTION
Chronic pancreatitis (CP) is a self-sustaining, progressive
inflammatory disease, associated with an increased risk for
developing pancreatic cancer, impaired quality of life, and
markedly decreased life expectancy (Kleeff et al., 2017). The heavy
disease burden is still aggravated by the lack of specific therapy,
which is due to our poor understanding of the pathomechanism,
with special regard to early-phase CP. Obstruction of the
pancreatic ducts by mucoprotein plugs and calcified stones
are hallmark histological features of CP and it has been
postulated that ductal obstruction may be an early event in
the pathogenesis. In the 1960s, Sarles et al. (1965) documented
the formation of a mucoprotein gel in the small pancreatic
ducts of CP patients with apparent focal fibrotic lesions, acinar
atrophy, and ductal dilatations upstream to the obstruction,
suggesting that ductal plugging occurs prior to parenchymal
damage. These features are reminiscent of the ones seen in the
pancreas of patients with cystic fibrosis (CF), indicating that
impaired cAMP-dependent chloride and bicarbonate secretion
by the CF transmembrane conductance regulator (CFTR)
anion channel is a key mechanism in the development of
ductal plugs. Indeed, diminished HCO−3 secretion is a well-
known and early defect in CP (Braganza and Rao, 1978;
Freedman, 1998), and numerous studies demonstrated that
pancreatitis-associated toxic factors, such as ethanol (Maléth
et al., 2015), cigarette smoke extract (Raju et al., 2013), bile
acids (Venglovecz et al., 2008), and trypsin (Pallagi et al.,
2011) display inhibitory effect on bicarbonate secretion by
decreasing the activity and the expression of CFTR. Insufficient
ion and fluid secretion leads to protein hyperconcentration
that predisposes to protein precipitation in the pancreatic juice,
which has been demonstrated in alcoholic CP and CF patients
(Sahel and Sarles, 1979; Kopelman et al., 1985; Freedman et al.,
1993). Another important but often overlooked determinant of
pancreatic ductal plugging is mucus production. Ductal cells
express mucins, heavily O-glycosylated, membrane-bound, or
secreted (gel-forming) glycoproteins that generate a protective
layer of mucus on the epithelial surface. In many epithelial
organs, mucus layer serves as a physical, chemical, and biological
barrier with important host-defense functions, while in the
pancreas it could provide protection against autodigestion
or bile acid reflux. The most frequent pancreatic epithelial
proliferative change is mucinous cell hypertrophy, also known
as ductal non-papillary hyperplasia, goblet cell metaplasia, or
as most recently classified, PanIN-1A (Hruban et al., 2001). It
designates the replacement of the normal ductal epithelium by
tall columnar cells with basal nuclei and abundant supranuclear
mucus that may occur in ducts of every size. Although there
are various reports on the natural prevalence of mucinous
cell hypertrophy (Walters, 1965; Cubilla and Fitzgerald, 1976;
Allen-Mersh, 1988; Sipos et al., 2009), a comparative study
found higher frequency in CP patients, than in controls without
pancreatic disease (60% and 16%, respectively) (Andea et al.,
2003), suggestive of increased mucus secretion. Supporting
this notion, there are reports of increased mucopolysaccharide
concentration (Wakabayashi and Takeda, 1976) and abundant
mucus content of precipitated plugs in the pancreatic juice
of CP patients (Harada et al., 1981). However, several studies
led to the general belief that protein precipitates originate
solely from acinar cell secretion (Guy et al., 1983; Freedman
et al., 1993; Ko et al., 2012), which could be due to a
number of challenges of mucus biochemistry, as isolating,
detecting, and visualizing large molecular weight and highly
glycosylated mucins require specific methodology (Mucins,
2018).
The biophysical properties of mucus are essentially
determined by HCO−3 (Quinton, 2008). In mucus-producing
cells, negatively charged mucin macromolecules are highly
condensed in secretory granules, where high Ca2+ concentration
and low pH (∼6) provide cationic shielding of intragranular
charge. Upon exocytosis mucin polymers rapidly expand their
volume up to 1000-fold and HCO−3 promotes this swelling and
hydration process by chelating Ca2+ ions and buffering protons,
thereby facilitates the formation of a proper gel (Chen et al.,
2010). In CF-affected organs, the lack of CFTR-mediated HCO−3
secretion leads to a tenacious, viscous mucus, and importantly,
it has been shown that adding bicarbonate can restore the
rheological properties of CF mucus (Gustafsson et al., 2012).
It is plausible that increased mucin secretion together with
reduced ductal bicarbonate/fluid transport in CP generates a
thick, viscous mucus that may obstruct the outflow of pancreatic
enzymes. Defective mucus hydration, as a result of a primary
defect in epithelial ion transport or due to hypersecretion of
“dry” mucin macromolecules, has been established as a key
pathomechanism in a spectrum of muco-obstructive lung
diseases, such as CF, chronic obstructive pulmonary disease
(COPD), and asthma (Button et al., 2016). To date, a number
of drugs are available that target mucus dehydration in these
respiratory disorders and there are ongoing efforts to develop
new strategies for more effective treatment options (Randell and
Boucher, 2006; Balsamo et al., 2010; Tildy and Rogers, 2015;
Mall, 2016). Despite these advances, our current understanding
of the role of mucus obstruction in the pancreas remains
limited. In the present study, we aimed to investigate the early
phase of CP. Utilizing human tissue samples and a murine
model of CP we have measured the pancreatic ductal mucus
content and the relative expression of different mucins in
health and disease. Using in vivo and in vitro techniques, we
have investigated pancreatic fluid secretion over the course of
experimental CP and we correlated these with the time-changes
of mucin production. Finally, to evaluate possible effect of CFTR
we analyzed mucin secretion changes in Cftr knock-out mice
pancreata.
MATERIALS AND METHODS
Ethical Approval
All experiments were approved by local ethical committees
on investigations involving animals at University of Szeged,
University of Heidelberg, and at University of Greifswald.
Studies involving human tissues were approved by the Human
Investigation Review Board at University of Szeged.
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Human Pancreas Tissues
Formalin-fixed paraffin-embedded human CP tissue samples
were provided by the Department of Pathology, University
of Szeged. Control tissue samples were obtained from brain
dead organ donors in cooperation with the Hungarian Organ
Coordination Office.
Experimental Animals
Experimental CP was modeled in 8- to 20-week-old mice on
FVB/N background. Chronic pancreatic injury was induced by
repetitive administration of cerulein with a treatment protocol
as follows (Xue et al., 2015): 6-times hourly intraperitoneal
injections of 50 µg/kg cerulein, 3 days a week, during a 1–
2–3–4-week-period. Controls were treated with physiological
saline. Two days after the last injection mice were sacrificed
and pancreata were removed. Gut-corrected CF (Cftr−/−) mice
overexpressing human CFTR in the intestine under control of
the fatty acid-binding protein promoter (Fabp-hCFTR-Cftr−/−)
on the FVB/N background were kindly provided by Dr. Jeffrey
A. Whitsett and genotyped, as previously described (Zhou et al.,
1994).
Histology and Mucus Morphometry
Pancreata were immersion fixed in 4% buffered formalin and
embedded in paraffin. To detect mucus, 5 µm sections were
cut and stained with alcian blue periodic acid-Schiff (AB-PAS)
staining. Images were taken with an Olympus IX-71 microscope
interfaced with a SIS Colorview I Camera Set (Olympus,
Hamburg, Germany) using the 10× and 40× objective. To
quantify secreted mucus, morphometric analysis of stained
sections were carried out by determining mucus volume density
using CellF Software, as previously described (Mall et al., 2008).
In brief, the length of the basal membrane of the ductal
epithelium was measured by the interactive image measurement
tool, and the AB-PAS positive surface area within this boundary
was measured by phase analysis according to the automatic
threshold settings of the software. The volume density of ductal
epithelial mucus, representing the volume of ductal mucus
content per surface area of the mucus basal membrane (nl/mm2),
was determined from the epithelial surface area of AB-PAS
positive mucus and the length of the basal membrane of the
ductal epithelium. Luminal mucus content relative to luminal
area was determined in a similar fashion. In case of mixed (pink
proteinaceous and alcian-blue positive mucus) intraluminal
material an additional phase analysis step was introduced to
determine the overall area of luminal content within the lumen
(Supplementary Figure 1). In case of human samples, one section
per tissue block was stained and all ducts within the given
section were analyzed. To determine the sampling protocol in
mice, we examined homogeneity of mucus changes within the
tissue by preparing serial sections of the pancreas of a 4-week
cerulein-treated animal, where we measured comparable mucus
volume densities throughout the pancreas (reviewed but not
shown). Therefore, we sampled one section per tissue and all
ducts were analyzed within 10 random fields of view with a 10×
objective.
Real Time RT-PCR
We have analyzed expression of different mucins in human
and mouse pancreata. Total RNA was isolated from frozen
tissue using RNeasy Mini Kit (Qiagen, Hilden, Germany),
while RNA from paraffin-embedded tissue was isolated with
RNeasy FFPE Kit (Qiagen, Hilden, Germany). Two micrograms
of RNA was reverse transcribed using High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City,
CA, United States) in the presence of RNase inhibitor RNasin
Plus (Promega, Fitchburg, WI, United States). Real-time PCR
reactions of mouse samples were performed with Taqman
RT-PCR assays (MM00449604_m1 Muc1, MM00466886_m1
Muc4, MM00466391_m1 Muc5b, MM00725165_m1 Muc6;
Thermo Scientific, Darmstadt, Germany), while analysis
in human samples was performed with maxima SYBR
Green/ROX qPCR Master Mix (2×) (Fermentas, St. Leon-
Rot, Germany). Human primers were designed according to
the reference sequences of MUC1, MUC4, MUC5B, MUC5AC,
and MUC6 genes (Table 1). Reactions were carried out
with ABI PRISM 7000 Sequence Detection System (Applied
Biosystems, Foster City, CA, United States) platform with
the following conditions: 10 min initial denaturation at
95◦C, followed by 40 two-step cycles: 15 s at 95◦C and
1 min at 60◦C. Threshold cycle (CT) values were determined
using the 7000 Sequence Detection System Software V.1.2.3.
Relative expression was calculated using the comparative CT
method (11CT method). Expression level of the gene of
interest was first normalized to the human glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) or mouse β-actin
(Actb) internal control gene (1CT) and then to expression
levels measured in control tissue (11CT). Results were
expressed as fold changes calculated with the formula
2−11CT.
Magnetic Resonance Imaging of
Pancreatic Fluid Secretion In Vivo
Magnetic resonance imaging (MRI) was performed to measure
the total excreted volume of pancreatic fluid after secretin
stimulation in control and 4-week cerulein-treated mice (Maléth
et al., 2015). For this purpose, animals were allowed free access to
pineapple juice for 12 h before the MRI examination, serving as
TABLE 1 | Primer sequences used for human mucin transcript analysis (5’→3’).
MUC1-Forward AGACGTCAGCGTGAGTGATG
MUC1-Reverse AGAACACAGACCAGCACCAG
MUC4-Forward CTCAATCAGTACCCGCCCTC
MUC4-Reverse GCTGTCTCTGAGCGTGAAGT
MUC5AC-Forward TCCACTATGAGTGCGAGTGC
MUC5AC-Reverse AGGACATAGGTGCAGTTGCC
MUC5b-Forward TATGTGCTGACCAAGCCCTG
MUC5b-Reverse GCTCAGTGTCACGCTCTTCA
MUC6-Forward CAGTACACACAGGAGGCCAA
MUC6-Reverse GGAGCAGTTGTAGCAGCCTT
GAPDH-Forward CACCATCTTCCAGGAGCGAG
GAPDH-Reverse GACTCCACGACGTACTCAGC
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an oral negative contrast agent. Small animal MRI was performed
in a 7.1-Tesla animal scanner (Bruker, Ettlingen, Germany)
using a mouse whole body coil. Strong T2-weighted series of
the entire abdomen were acquired before and after retroorbital
injection of 10 IU units/kg secretin (ChiroStim, ChiRhoClin,
Burtonsville, MD, United States). Both MRI sequences (before
and after secretin injection) were acquired using the same
image protocol with the following image parameters: TR/TE
4400/83 ms; flip angle: 180◦; matrix 256 × 256; field of
view 40 × 40 mm; bandwidth 315 hz/pixel; slice thickness
1 mm; 20 slices. One observer with >12 years of experience
in GI radiology reviewed the images using the software Osirix
(version 5; Pixameo, Bernex, Switzerland). First, we reduced
image noise to minimize artifacts in images. Second, fluid
excretion into the small intestine was segmented in each slice.
Fluid excretion was defined as areas in the bowel with high
signal intensity. Care was taken to avoid artifacts caused by
magnetic inhomogeneity and motion especially bowel motion.
The volume of intestinal fluid was assessed before and after
secretin stimulation. From these data total excreted volume
was assessed. Measured values were normalized to control
mice.
Measurement of Pancreatic Fluid
Secretion In Vitro
Fluid secretion into the closed luminal space of the cultured
mouse pancreatic ducts was analyzed using a swelling
method developed by Fernández-Salazar et al. (2004). Briefly,
intra/interlobular pancreatic duct fragments were isolated by
microdissection from the pancreas of control and cerulein-
treated mice. After 6 h of incubation sealed ducts were
attached to a coverslip precoated with poly-L-lysine in the
base of a perfusion chamber (0.45 ml). Bright-field images
were acquired at 1 min intervals using a CCD camera (CFW
1308C, Scion Corporation, Frederick, MD, United States).
First, baseline images were taken in HEPES-buffered solution
(140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2,
10 mM Glucose, 10 mM HEPES, pH 7.5), then chamber was
perfused with HCO−3 containing solution (115 mM NaCl,
5 mM KCl, 25 mM NaHCO3, 1 mM CaCl2, 1 mM MgCl2,
10 mM Glucose). To stimulate ductal secretion 100 µM
3-isobutyl-1-methylxanthine (IBMX) and 5 µM forskolin
were added to the perfusate. The integrity of the duct wall
was checked at the end of each experiment by perfusing
the chamber with a hypotonic solution (HEPES-buffered
solution diluted 1:1 with distilled water). Digital images of
the ducts were analyzed using ImageJ software to obtain
values for the area corresponding to the luminal space in each
image.
Statistics
Quantitative variables were described as mean ± SE. Significant
differences between groups were determined by Student’s t-test
or by analysis of variance with Dunnett’s post hoc analysis. All the
analyses were performed with GraphPad Prism (San Diego, CA,
United States).
RESULTS
Mucus Content Is Increased in Small
Ducts in Chronic Pancreatitis
Utilizing AB-PAS for staining mucus and quantitative
histological approach we compared the pancreatic morphology
of human control and CP tissue samples. AB-PAS-stained
sections revealed a predominantly alcian-blue positive staining
of the pancreatic mucus, indicating the presence of acidic
mucopolysaccharides. Mucus was localized to the epithelial
surfaces and to the luminal area of pancreatic ducts. In the
case of control pancreata, there was little or no mucus present
in intralobular ducts, while in CP tissue small ducts exhibited
substantial amounts of mucus that often completely plugged
the lumen (Figures 1A–D). Morphometric analysis revealed a
significant increase of epithelial mucus content in small ducts
(diameter <100 µm), while no difference was observed in
large interlobular ducts (Figure 1E). In concordance with the
epithelial mucus measurements we found increased intraluminal
mucus in the smallest ducts in CP, while proteinaceous material
was less prevalent, which could reflect decreased acinar secretion,
i.e., exocrine dysfunction in CP (Supplementary Figures 2A,B).
Next, we examined the mucus changes in experimental
CP. Pancreatic damage was induced with 4 weeks of cerulein
injections in mice. In contrast to the human situation, alcian-blue
positive staining was virtually absent in the ducts of control mice.
Although intestinal-type goblet cells were present at the level of
the common bile duct, they shortly disappeared from the main
duct (data not shown). In cerulein-induced CP tissue formation
of novel ductal structures due to acinar-to-ductal metaplasia
(ADM) was apparent. Similarly to human CP, we found alcian-
blue positive mucus on the surface of the ductal epithelium
and intraluminally in small ducts (Figures 1F–I). Morphometric
analysis showed that mucus volume density was significantly
higher in small ducts (diameter<60µm) in cerulein-treated mice
(Figure 1J). Quantification of the luminal compartment revealed
increased amount of intraluminal mucus in the smallest ducts as
well (Supplementary Figure 2C).
Secretory Mucins Are Differentially
Expressed in Human and Experimental
Chronic Pancreatitis
Mucus accumulation in the small ducts could be a result
of hypersecretion or due to insufficient removal/flush-out. To
identify secretory changes, we analyzed tissue mRNA expression
of different mucins in human. We found that secreted mucins
MUC5B and MUC6 were significantly upregulated in CP
(Figure 2A) suggesting epithelial mucus hypersecretion. Another
secreted mucin MUC5AC was not detectable in most of the
samples (8/9 control and 10/11 CP). Membrane-bound mucins
MUC1 and MUC4 were not significantly altered, although
normalization of MUC4 samples was hampered as many samples
were below detection limit (6/9 control and 4/11 CP).
In cerulein-induced murine CP we found that Muc6, but not
Muc5b was upregulated by three orders of magnitude, indicating
that Muc6 glycoprotein is the dominant secreted mucin in the
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FIGURE 1 | Representative morphology of AB-PAS stained human pancreata (A–D). The epithelial cells of an interlobular duct in control (A) and CP (B) tissue are
lined with a thin layer of mucus (arrows). A small intralobular duct in control tissue (C) shows no mucus staining. An intralobular duct in CP (D) is filled with
inspissated mucus (asterisk). Morphometric analysis of epithelial mucus volume density of pancreatic ducts in control and CP human tissues (E). N = 9–9 tissue
samples, N = 178–185 total number of analyzed ducts in control and CP, respectively, N = 15–71 ducts per group. Data are shown as pooled average over all ducts
in control and CP group. Representative morphology of AB-PAS stained mouse pancreata (F–I). A large interlobular duct in control tissue shows no mucus staining
(F). A large interlobular duct in 4-week cerulein induced CP (G) with little mucus staining surrounded by numerous small ducts that contain mucus. A small
intralobular duct in control tissue with no mucus (H). A cluster of small ducts in CP shows epithelial mucus lining (arrows) and inspissated mucus (asterisk) (I).
Morphometric analysis of epithelial mucus volume density of pancreatic ducts in control and 4-week cerulein-treated mice (J). N = 9–9 tissue samples and
N = 64–186 total number of analyzed ducts in control and 4-week cerulein treated mice, respectively, N = 4–116 ducts per group. Data are shown as pooled
average of all ducts in control and treated group. ∗∗∗P < 0.001.
mouse pancreatic duct (Figure 2B). Membrane-bound mucin
Muc1 was downregulated that could be attributed to lower
number of acinar cells, that also express Muc1.
Pancreatic Ductal Fluid Secretion Is
Decreased in Experimental CP In Vitro
and In Vivo
Defective mucus hydration may develop if increased mucus
secretion is accompanied by an epithelial ion and fluid transport
defect. To assess the pancreatic ductal function in CP we applied
two different techniques. First, we used magnetic resonance
imaging cholangiopancreatography (MRCP) to measure total
excreted volume in control and 4-week cerulein-treated mice
in vivo (Figures 3A,B). Two days after the last injection, MRCP
images were taken on baseline and upon secretin stimulation. We
found that the total excreted volume was significantly decreased
in CP mice compared to the controls (Figure 3C). In order to
gain insight into the time-changes of ion and fluid transport,
we examined pancreatic ductal secretory function in vitro using
different cerulein treatment time-series. We isolated pancreatic
duct fragments from control and 1–2–3–4-week cerulein-treated
mouse pancreata, and measured fluid secretion by the swelling
assay. Basal ductal secretion in HCO−3 containing buffer in
4-week cerulein-treated mice was significantly lower, than in
controls. Upon administration of IBMX and forskolin, stimulated
fluid secretion was markedly reduced in 3- and 4-week cerulein-
treated mice (Figures 3D,E).
Muc6 Is Associated With Altered Ion
Transport
Next, we aimed to determine the relationship of the development
of the mucus obstruction phenotype and impairment of ductal
fluid secretion over time. We examined Muc6 transcript
levels in pancreata from 1–2–3–4-week cerulein-treated mice
and found significant upregulation at 3 and 4 weeks of
treatment (Figure 4A), parallel to the timing of changes of
fluid secretion in CP. To further investigate the relationship
between Muc6 and altered epithelial ion transport we examined
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FIGURE 2 | Mucin mRNA expression panel in human (A) control and CP pancreatic tissue samples. N = 9–11. Mucin mRNA expression panel in mouse (B) control
and 4-week cerulein-treated tissue samples. N = 9–9. n.d. = not detected. ∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05.
Muc6 mRNA expression in the pancreas of long-lived (29–
31 weeks old) Cftr−/− mice in comparison with their age-
matched Cftr+/+ littermates. Muc6 mRNA was approximately
threefold upregulated in Cftr−/− pancreas (Figure 4B).
DISCUSSION
In our study we demonstrate increased epithelial mucus
production in the small pancreatic ducts in the early phase of
CP, which is paralleled by an impairment of pancreatic ductal
fluid secretion. The evidence we present here supports that mucus
dehydration is an important aspect of the early-pathogenesis and
argues the rationale for therapeutic targeting of defective mucus
in CP.
Inspissation of pancreatic ducts with mucoprotein material
has been long observed in CP, while pathology studies suggested
that mucinous cell hypertrophy and differential expression
of mucins associate with the disease (Hruban et al., 2008);
however, there has been no detailed quantitative and qualitative
characterization of mucus produced by the pancreatic ducts in
health and CP. In this study, we show higher amounts of mucus in
the epithelial cells and also in the lumens of small pancreatic ducts
in human CP, which was also replicated in a murine model of
cerulein-induced CP. In the normal pancreas, ductal cells secrete
high amounts of alkaline fluid that flushes out acidic, protein-
rich acinar secretion. Intercalated and intralobular ducts highly
express apical CFTR and they are the preferential sites of HCO−3
secretion (Ishiguro et al., 2012), while in acute and CP CFTR
expression decreases in these cells (Maléth et al., 2015). The
finding that the mucus phenotype localizes to the small peripheral
ducts suggests a common dysregulation with ion transport in CP.
Consistent with previous reports (Andrianifahanana et al.,
2006; Nagata et al., 2007) we found that MUC5B and MUC6
secretory mucins are upregulated in human CP, indicating a
hypersecretion of mucus.MUC5B is also expressed in the airways,
salivary glands, endocervix, and gall bladder, while MUC6 in
the stomach, duodenum, gall bladder, and the seminal vesicle
(Bartman et al., 1998). Interestingly, MUC6 transcript was found
in the centroacinar cells and intralobular ducts in the fetal
and postnatal pancreas with an expression pattern similar to
CFTR. Moreover, the same study showed MUC6 glycoprotein
in the luminal material in the pancreas of CF patients (Reid
et al., 1997). Another report also suggested increased Muc6
levels in Cftr−/− mouse pancreata (Gouyer et al., 2010, p. 6),
supporting the connection of MUC6 with ductal secretory
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FIGURE 3 | Representative images of magnetic resonance imaging cholangiopancreatography (MRCP) upon secretin stimulation in saline-treated control and
4-week cerulein-treated mice (A,B). Relative excreted volume measured by MRCP in control and 4-week cerulein-treated mice (C). N = 9–9 mice per group. Data
obtained from two independent repeats were normalized to the respective controls at end-point. Optical measurement tracings (D) and data summary (E) of
pancreatic ductal swelling in vitro of isolated duct fragments in saline-treated control and 1–2–3–4-week cerulein-treated mice. Bar charts summarize the relative
changes of volume in HCO-3 containing buffer (between 5 and 25 min) and upon IBMX/forskolin stimulated secretion (between 25 and 50 min). N = 5–14 mice per
group, N = 22–84 isolated ducts per group. Data are shown as pooled average of all ducts in treatment groups. ∗∗∗P < 0.001.
dysfunction. Strikingly, in cerulein-induced experimental CP
model Muc6 solely was greatly overexpressed, which implies that
the histologically observed mucus increase is a result of selective
Muc6 mucin hypersecretion.
These data raise the typical “chicken or the egg” question
whether increased mucus in the small ducts in CP is a result
of mucus hypersecretion complicated by a defective flush-out
mechanism, or primarily of an impaired ion and fluid transport
that leads to accumulation and obstruction of constitutively
secreted mucins, while mucus hypersecretion being secondary to
inflammatory stimulus. To investigate ductal secretory function,
we utilized two complimentary methods, MRCP in vivo and
ductal swelling assay in vitro in murine CP. The cerulein-
induced CP model causes repetitive injuries in the pancreas that
mirror recurrent acute attacks developing into CP as it occurs
in some patients (Lara and Levy, 2004). Although supramaximal
cerulein stimulation primarily affects acinar cells, resulting in
vacuolization, diminished secretion, and intrapancreatic enzyme
activation, the importance of ductal function in this model
has been outlined by several studies. In cerulein-induced acute
pancreatitis, fluid hypersecretion was observed in rats (Czakó
et al., 1997); furthermore, genetic deletion of Cftr (Dimagno
et al., 2005) as well as deletion of its trafficking regulator
Na+/H+ exchanger regulatory factor-1 (Nherf-1) (Pallagi et al.,
2014) resulted in a more severe acute pancreatitis phenotype in
mice. These studies indicate a protective wash-out mechanism
by the ducts relevant to this model, and to our knowledge, we
demonstrate for the first time evidence of an impaired ductal
function in cerulein-CP.
To gain insight into the development of the secretion
defect, we performed in vitro time-series experiments with
different treatment regimens and found that ductal fluid secretion
begins to decrease after 3 weeks of cerulein treatment. More
specifically, the cAMP-stimulated secretion abolished, which
could indicate CFTR dysfunction, although the authors admit
that time-matched traces without IBMX/Forskolin stimulation
or application of specific CFTR inhibitors would allow more
appropriate determination of CFTR function and the lack
thereof. After 4 weeks of treatment we observed a decrease
of basal secretion as well, where one could speculate further
involvement of anion exchangers.
To correlate these time-changes with the development of
mucus phenotype, we examined Muc6 expression in different
treatment schedules. Marked overexpression was observed
after 3 weeks treatment, which corresponded to the time-
point of deteriorating ductal secretion, showing that mucus
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FIGURE 4 | Muc6 mRNA expression analysis in pancreatic tissue from control
and 1–2–3–4-week cerulein-treated mice (A). N = 9–11, ∗∗∗P < 0.001,
∗P < 0.05. Muc6 mRNA expression analysis in pancreatic tissue from 29- to
31-week-old Cftr knock-out mice and wild-type littermates (B). N = 5–6,
∗P < 0.05.
hypersecretion is paralleled by an epithelial electrolyte transport
defect. As a proof of concept, we examined Muc6 expression
in long-lived Cftr−/− mice. These mice do not exhibit overt
pancreas pathology, but age-dependently they develop mild
features consistent with progressive ductal obstruction, such
as lower acinar cell count and distended ductal lumina with
inspissated material (Durie et al., 2004). Although we did not see
mucus histologically (data not shown) Muc6 transcript analysis
showed an overexpression in Cftr−/− mice, demonstrating that
Muc6 can be induced by a basic transport defect.
Taken together these data could suggest a common
dysregulation of CFTR and mucus, namely: (i) mucus
accumulates in the small ducts, where CFTR is localized,
(ii) cAMP-dependent secretion defect is paralleled by mucus
hypersecretion, and (iii) Muc6 is overexpressed in Cftr−/−
mouse pancreata. These observations would also argue that
increased Muc6 secretion in CP develops early with impaired
ion transport, rather than as a consequence of sustained
inflammation. This possibility would be analogous to the
pathomechanism of mucus stasis in smoking-related COPD.
Cigarette smoke exposure induces mucin overexpression and
impairs CFTR-mediated Cl− secretion in the airways, which
results in decreased mucociliary clearance and mucus plugging
(Button et al., 2016). In contrast to tobacco-induced acquired
CFTR deficiency, mucus hypersecretion in CF lung disease
develops secondary to inflammatory response. In CF airways, the
underlying transport defect causes airway surface dehydration,
mucus hyperconcentration, and impaired mucus clearance,
which triggers chronic inflammation and microbial infections. In
this inflammatory environment, numerous cytokines, proteases,
and bacterial products mediate mucus hypersecretion and goblet
cell metaplasia, further aggravating mucus plugging (Button
et al., 2016).
Alternatively, increased mucus production may develop as
a response to inflammation in pancreatitis, preceding ductal
obstruction. In cerulein, hyperstimulation, inflammation, and
cell death appear already 4–6 h after injury of and take 12–24 h
to reach maximum levels (Lerch and Gorelick, 2013). During
the course of cerulein CP oxidative stress, inflammatory cytokine
production and neutrophilic infiltration are present already after
the first attack and it is plausible that these could be potent signals
for increased mucus secretion in ductal cells. Due to cellular
injury in murine CP ADM develops through dedifferentiation
of acinar cells (Storz, 2017). In ADM a developmental program
is activated with the expression of genes that are active during
embryonic development or normally restricted to uninjured
ductal cells and is believed to represent a defense mechanism in
pancreatitis. Increased mucus secretion could also be part of this
repair program possibly providing a barrier in leaky ducts with
increased paracellular permeability.
However, imbalance between mucus production and ductal
flush-out mechanism may be detrimental which leads to mucus
plugging, delaying the outflow of digestive enzymes, and
triggering intrapancreatic zymogen activation. Our data indicate
defective mucus hydration and increased mucus viscosity in
the small pancreatic ducts due to mucus hypersecretion and
impaired ductal fluid secretion. The luminal content we observed
histologically predominantly consisted of mucus in the small
ducts in CP (Supplementary Figures 2A,B). This mucoprotein
material, a viscous mixture of hyperconcentrated mucus and
acinar secretion, can readily block narrow lumens, or may
also serve as a nidus for calcification. There is a body of
evidence on the importance of ductal wash-out mechanism on
the integrated function of acinar and ductal cells (Hegyi and
Petersen, 2013). Impaired epithelial ion and fluid secretion due
to CFTR dysfunction leads to acidification of intraluminal pH
(Takács et al., 2013), which may lead to premature intra-acinar
and intraluminal trypsinogen activation (Sherwood et al., 2007;
Pallagi et al., 2011), while active trypsin can further inhibit
CFTR via luminal PAR2 receptor cleavage (Pallagi et al., 2011).
Moreover, elevated upstream pressure in plugged ducts can
further decrease HCO−3 secretion via neuroendocrine signaling
(Suzuki et al., 2001). Altogether, ductal obstruction generates
a vicious cycle of pathological processes that may explain the
sustained and progressive nature of the inflammation in CP.
It is conceivable that therapeutic approaches aiming to
resolve mucoprotein obstruction can break the cycle of
irreversible progression. Animal models suggest that therapeutic
interventions at early-stage disease could have the greatest impact
on progression and prognosis (Vonlaufen et al., 2011). However,
the clinical frameworks of early CP are not established as
diagnosis mostly relies on end-stage pathology (Kleeff et al.,
2017). On the other hand, recurrent acute pancreatitis (RAP)
is clinically well-defined syndrome (acute pancreatitis attacks
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without radiological evidence of CP), which may progress into
CP; therefore, it could be conceptually viewed as potential
early CP. Future studies in this subgroup of patients will
advance our understanding on human pathogenesis, progression,
and offer the possibility to investigate early intervention
strategies.
Decreased pancreatic fluid secretion in CP may be associated
with CFTR dysfunction (Hegyi et al., 2016) and we speculate that
pharmacological targeting would be beneficial in CP. Increased
ductal bicarbonate secretion could improve the hydration and
the rheological properties of mucus and facilitate wash-out
from the ductal system. To date a number of small molecule
CFTR modulators have been developed to rescue the basic
defect in patients with CF. Although drug discovery programs
were designed to restore specific CFTR mutations, these agents
may also promote the function of wild-type CFTR. In vitro
data demonstrated that ivacaftor, the first approved CFTR
modulator, has the potential to counteract tobacco-induced
CFTR dysfunction in COPD (Sloane et al., 2012). These
promising results suggest that already available modulators
may be effective for the restoration of CFTR function in
CP. Mechanical approaches to resolve ductal plugging have
been in clinical use. Extracorporeal shock wave lithotripsy
(ESWL) can be applied in chronic calcifying pancreatitis for
the clearance of large calcified stones, which has proved very
effective in alleviating pain symptoms, and some authors even
reported improvement of exocrine/endocrine function of the
gland (Choi and Kim, 2006). However, calcifications may develop
long after mucoprotein plugging, when irreversible damage
has already occurred. A very interesting clinical study tested
the effect of bromhexine-hydrochloride in a small cohort of
non-abstinent alcoholic CP patients (Tsujimoto et al., 2005).
Bromhexine is an oral over-the-counter drug used as a bronchial
mucolytic (Zanasi et al., 2017). Bromhexine use for 6 months
improved clinical symptoms in 8/12 patients and importantly,
significantly increased fecal chymotrypsin, indicating exocrine
improvement. Although the mechanism of action is unknown,
this finding encourages further studies on muco-active agents
in CP.
In the present paper, we introduce important aspects of
mucus secretion defect in CP such as localization, timing,
molecular identification of secreted mucins, but there are
several limitations. First, increased luminal mucus was apparent
by histological analysis in CP; however, the fixation and
embedding process may not optimally preserve intraluminal
material and therefore interpretation of these results should
be taken with caution. Due to our limited access to human
samples, direct examination of mucus content in the pancreatic
juice was not possible, although this would also help to
elucidate the potential role of mucus as a biomarker in CP.
Second, the triggering factor for mucin overproduction remains
elusive. Inflammatory cell infiltration, cytokine production, and
oxidative stress in CP are likely candidates, on the other
hand, association of Muc6 overexpression with impaired ion
transport would argue that noxious agents that inhibit CFTR
function would also induce mucin hypersecretion. To test
these possibilities development of a translational in vitro model
system will be necessary that allows quantitative examination
of electrolyte transport and mucus secretion changes. To
achieve this goal recently introduced disease relevant human
organoid cultures may be instrumental (Hohwieler et al., 2017).
Third, our assays show a link between CFTR dysfunction and
mucus dehydration but further confirmation by mechanistic
investigations is needed to elucidate the direct role of CFTR-
mediated bicarbonate transport on the regulation of mucus
secretion, mucus rheology, and the development of ductal
obstruction in the pancreas.
CONCLUSION
We have demonstrated here that mucus accumulates in the small
pancreatic ducts in CP, which is a combined result of mucin
hypersecretion and decreased ductal flush-out mechanism. The
observations presented here are consistent with defective mucus
hydration associated with impaired epithelial ion transport,
which presents important therapeutic implications for CP.
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